Waters Corporation (WAT) Shares Sold by Cypress Capital Group
Cypress Capital Group lessened its holdings in shares of Waters Corporation (NYSE:WAT) by 16.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,946 shares of the medical instruments supplier’s stock after selling 778 shares during the period. Cypress Capital Group’s holdings in Waters were worth $709,000 at the end of the most recent reporting period.
A number of other large investors have also made changes to their positions in WAT. Oppenheimer Asset Management Inc. grew its holdings in shares of Waters by 0.4% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock worth $105,000 after acquiring an additional 2 shares during the period. ETF Managers Group LLC purchased a new position in shares of Waters during the 2nd quarter worth approximately $106,000. Intellectus Partners LLC grew its holdings in shares of Waters by 4.9% during the 2nd quarter. Intellectus Partners LLC now owns 667 shares of the medical instruments supplier’s stock worth $123,000 after acquiring an additional 31 shares during the period. Edmond DE Rothschild Holding S.A. purchased a new position in shares of Waters during the 2nd quarter worth approximately $160,000. Finally, Acrospire Investment Management LLC grew its holdings in shares of Waters by 117.4% during the 2nd quarter. Acrospire Investment Management LLC now owns 926 shares of the medical instruments supplier’s stock worth $170,000 after acquiring an additional 500 shares during the period. Institutional investors own 92.29% of the company’s stock.
Shares of Waters Corporation (NYSE:WAT) traded down $0.26 on Wednesday, reaching $197.50. 429,800 shares of the company’s stock were exchanged, compared to its average volume of 513,713. The stock has a market cap of $15,728.45, a price-to-earnings ratio of 27.47, a PEG ratio of 2.87 and a beta of 0.82. The company has a debt-to-equity ratio of 0.66, a quick ratio of 5.71 and a current ratio of 6.16. Waters Corporation has a 1-year low of $133.71 and a 1-year high of $201.95.
Waters (NYSE:WAT) last announced its earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.03. The business had revenue of $565.58 million during the quarter, compared to analyst estimates of $555.25 million. Waters had a net margin of 24.34% and a return on equity of 23.61%. The company’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.57 EPS. research analysts expect that Waters Corporation will post 7.42 earnings per share for the current fiscal year.
A number of analysts have recently commented on the company. Morgan Stanley raised Waters from an “underweight” rating to an “equal weight” rating and set a $192.00 price target on the stock in a research report on Monday, December 4th. Bank of America boosted their price target on Waters from $192.00 to $202.00 and gave the stock a “neutral” rating in a research report on Friday, November 10th. Cowen reissued a “hold” rating and issued a $190.00 price target on shares of Waters in a research report on Friday, November 3rd. Zacks Investment Research cut Waters from a “buy” rating to a “hold” rating in a research report on Thursday, October 26th. Finally, Citigroup reissued a “neutral” rating and issued a $180.00 price target on shares of Waters in a research report on Wednesday, October 25th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Waters presently has a consensus rating of “Hold” and an average price target of $193.62.
In other news, SVP Rohit Khanna sold 26,913 shares of the company’s stock in a transaction on Friday, October 27th. The stock was sold at an average price of $197.93, for a total value of $5,326,890.09. Following the completion of the sale, the senior vice president now directly owns 13,677 shares in the company, valued at approximately $2,707,088.61. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Elizabeth B. Rae sold 12,000 shares of the company’s stock in a transaction on Friday, November 3rd. The stock was sold at an average price of $197.95, for a total value of $2,375,400.00. Following the completion of the sale, the senior vice president now owns 18,129 shares of the company’s stock, valued at $3,588,635.55. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 45,913 shares of company stock valued at $9,084,685. Company insiders own 5.07% of the company’s stock.
WARNING: “Waters Corporation (WAT) Shares Sold by Cypress Capital Group” was originally published by Watch List News and is the property of of Watch List News. If you are viewing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright legislation. The legal version of this story can be accessed at https://www.watchlistnews.com/waters-corporation-wat-shares-sold-by-cypress-capital-group/1761712.html.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with Analyst Ratings Network's FREE daily email newsletter.